Literature DB >> 23723582

Extraosseous Tc-99m methylene diphosphonate concentration in the forearm following post-mastectomy lymphatic obstruction.

Anish Bhattacharya1, Madan Parmar, Bhagwant Rai Mittal.   

Abstract

A 42-year-old female patient with a past history of right breast cancer and recent onset swelling of the right forearm underwent routine whole-body bone scintigraphy with Tc-99m methylene diphosphonate, 2 years after a modified radical mastectomy. Diffuse soft tissue tracer concentration was seen in the right forearm. Subsequent lymphoscintigraphy using Tc-99m sulphur colloid revealed obstructed lymphatic drainage in the right upper limb.

Entities:  

Keywords:  Extraosseous; Tc-99m methylene diphosphonate; lymphoscintigraphy; mastectomy

Year:  2012        PMID: 23723582      PMCID: PMC3665135          DOI: 10.4103/0972-3919.110696

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


INTRODUCTION

Lymphedema is a common complication of breast cancer treatment, especially after axillary lymph node dissection and radiotherapy. This condition may become apparent during routine bone imaging with Tc-99m methylene diphosphonate (MDP). In such cases, lymphoscintigraphy can be used to confirm obstruction to lymphatic drainage.

CASE REPORT

A 42-year-old female patient with a history of right breast cancer reported recent onset swelling of the right forearm. She had undergone modified radical mastectomy 2 years previously, with subsequent chemotherapy and radiotherapy. A routine whole-body bone scan was performed to assess any skeletal involvement. Following intravenous injection of 740 MBq (20 mCi) of Tc-99m MDP, imaging was performed after 3 hours under a dual head gamma camera (Ecam, Siemens, Germany) fitted with a low-energy high-resolution collimator. Diffuse soft tissue uptake of tracer in the right forearm, extending to the right elbow was noted [Figure 1]. No bony abnormality was detected.
Figure 1

Anterior (a) and posterior; (b) whole-body bone scan images showing diffuse soft tissue uptake of tracer in the right forearm (arrows)

Anterior (a) and posterior; (b) whole-body bone scan images showing diffuse soft tissue uptake of tracer in the right forearm (arrows) A provisional diagnosis of lymphatic obstruction in the right upper limb was made and lymphoscintigraphy was performed during the patient's next visit, 7 days later. Unfiltered Tc99m-sulphur colloid (20 MBq) was injected intradermally into the second and third web spaces of each hand, and whole body images were acquired after 10 min and 2 hours under the same gamma camera, with the arms raised above the head. The 10-min image showed rapid movement of tracer into the left trochlear and axillary lymph nodes, with minimal tracer movement in the region of the distal right forearm. The delayed image showed diffuse soft tissue concentration of tracer only in the distal part of the right forearm, with no further ascent, indicating lymphatic obstruction [Figure 2].
Figure 2

Lymphoscintigraphy at 10 minutes (a) and 2 hours; (b) with the arms raised, showing rapid movement of tracer into the left trochlear and axillary lymph nodes (arrows), and diffuse soft tissue tracer uptake in the distal part of the right forearm (arrowhead)

Lymphoscintigraphy at 10 minutes (a) and 2 hours; (b) with the arms raised, showing rapid movement of tracer into the left trochlear and axillary lymph nodes (arrows), and diffuse soft tissue tracer uptake in the distal part of the right forearm (arrowhead)

DISCUSSION

Lymphedema is a common complication of breast cancer treatment, with a significantly higher incidence reported after axillary lymph node dissection and radiotherapy (38.3-42.4%) as compared to that by any one treatment modality alone (7.4-13.4%).[1-3] Post-mastectomy edema may be early and occur shortly after surgery, resulting from acute lymphatic overload, and decrease as compensatory pathways develop. Late lymphedema may develop months to years after surgery.[4] This condition is often progressive, attributed to lymphatic obstruction by surgical interruption or fibrosis and precipitates overload in already compromised lymphatic channels. Extraosseous soft tissue concentration of bone imaging agents like Tc-99m MDP and Tc-99m HMDP has been reported in conditions that cause hyperemia (i.e., inflammation, neovascularity, altered sympathetic tone with resultant vasodilatation) and altered capillary permeability, resulting in increased distribution of the tracer within the soft tissues.[5-7] The exact mechanism of non-osseous accumulation of bone scanning agents is still unclear; however, it has been proposed that Tc-99m MDP accumulates in serous effusions by directly exuding from the peripheral blood vessels to the serous cavity along with the increased blood flow, the increased vascularity and vascular permeability.[89]
  9 in total

1.  Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: pictorial review.

Authors:  J Kaye; Mike Hayward
Journal:  Australas Radiol       Date:  2002-03

2.  Gamut: soft tissue uptake of bone radiopharmaceuticals.

Authors:  Murat Tuncel; Belkis Erbas; Babak Mahmoudian
Journal:  Semin Nucl Med       Date:  2003-10       Impact factor: 4.446

Review 3.  Incidence of breast carcinoma-related lymphedema.

Authors:  J A Petrek; M C Heelan
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

4.  Postoperative lymphoedema after treatment of breast cancer.

Authors:  B Brismar; I Ljungdahl
Journal:  Acta Chir Scand       Date:  1983

5.  Unilateral increased radioactivity in the lower extremities on routine 99mTc-pyrophosphate bone imaging.

Authors:  R S Manoli; J S Soin
Journal:  Clin Nucl Med       Date:  1978-09       Impact factor: 7.794

6.  Accumulation of technetium-99m MDP in pseudomyxoma peritonei.

Authors:  T Kida; F Tsuda; Y Fujita; S Munakata; M Sasaki
Journal:  Ann Nucl Med       Date:  1990-11       Impact factor: 2.668

7.  Prevalence and risk factors for development of lymphedema following breast cancer treatment.

Authors:  S V S Deo; S Ray; G K Rath; N K Shukla; M Kar; S Asthana; V Raina
Journal:  Indian J Cancer       Date:  2004 Jan-Mar       Impact factor: 1.224

8.  Risk of lymphoedema following the treatment of breast cancer.

Authors:  M W Kissin; G Querci della Rovere; D Easton; G Westbury
Journal:  Br J Surg       Date:  1986-07       Impact factor: 6.939

9.  Extraosseous Tc-99m MDP uptake: a pathophysiologic approach.

Authors:  P J Peller; V B Ho; M J Kransdorf
Journal:  Radiographics       Date:  1993-07       Impact factor: 5.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.